ProMetic- Arriva Joint Patent is Validated in Europe – Treatment of Inflammatory Skin Diseases Using AAT Gains New Impetus For Clinical Trials

March 29, 2001
Posted by: Prometic Prometic
Posted In: Press Releases, Press Releases 2001
X